Tag Archives: T cell receptors

August, 2018

  • 23 August

    bluebird bio and Gritstone Oncology Collaborate to Develop Novel Cancer Cell Therapies

    CAMBRIDGE, Mass. & EMERYVILLE, Calif.–(BUSINESS WIRE)–bluebird bio, Inc. (Nasdaq: BLUE) and Gritstone Oncology, Inc. today announced a collaboration to research, develop and commercialize products for the treatment of cancer using cell therapy. Gritstone Oncology will leverage its proprietary EDGE™ artificial intelligence platform to analyze specific tumor types to identify tumor-specific targets and natural T-cell …

  • 6 August

    Regeneron and bluebird bio Collaborate for Development of New Cell Therapies for Cancer

    TARRYTOWN, N.Y. and CAMBRIDGE, Mass., Aug. 6, 2018 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and bluebird bio, Inc. (NASDAQ: BLUE) today announced a collaboration to apply their respective technology platforms to the discovery, development and commercialization of novel immune cell therapies for cancer. The collaborators will specifically leverage Regeneron’s VelociSuite® platform technologies for the discovery and characterization of fully human …

July, 2018

July, 2016

  • 13 July

    Treatment Targets HIV’s Last Hiding Place

    UK scientists may have found a way to destroy HIV’s last refuge. A study by Oxford University has confirmed that a treatment developed by a British company can remove the virus in its chosen hiding place, in laboratory conditions, offering hope of a viable treatment. Professor Lucy Dorrell and her …

January, 2016